Navigation Links
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Date:2/4/2009

EMERYVILLE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII), today announced the appointment of William A. Fletcher as the Company's Acting Chief Executive Officer. Mr. Fletcher has been a director of NTI since February 2007. With the Acting CEO appointment, the board of directors has discontinued its previously announced search for a permanent, full-time president and chief executive officer.

Mr. Fletcher has been Chairman, Teva Pharmaceuticals North America since December 2004. Prior to that, he was President and Chief Executive Officer of Teva's North American activities from 1985 until the end of 2004. Mr. Fletcher served as Vice President, Sales and Marketing of the Pennsylvania-based Lemmon Company (1980 to 1983) and then as President (1983-1985) following the company's acquisition by Teva and WR Grace. Mr. Fletcher graduated in International Marketing from Woolwich Polytechnic, London (now Greenwich University) in 1969.

"Together with the rest of the board of directors, I am committed to determining the best direction for Neurobiological Technologies as we evaluate alternatives following the failure of our Viprinex(TM) program for stroke. I intend to lead this process in a disciplined and expeditious manner," stated Mr. Fletcher. "We are continuing to downsize the Company while critically assessing our obligations and commitments in order to determine the best value for our shareholders."

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. is a biopharmaceutical company focused on developing novel, first-in-class agents for central nervous system conditions and other serious unmet medical needs. The company recently terminated development of its most advanced product candidate, Viprinex(TM) (ancrod), which was studied
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Neurobiological Technologies Reports Second Quarter Financial Results
2. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
3. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
4. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
5. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
6. Neurobiological Technologies Reports Going Concern Qualification
7. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
8. Patient Safety Technologies Closes $2.55 Million Financing
9. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
10. Medusa Medical Technologies Announces Integration of Siren ePCR Suite(TM) with Philips HeartStart MRx Monitor/Defibrillator
11. Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Four hospitals affiliated with the ... latest ranking of the country’s best hospitals by ... today and slated for publication in August, the U.S. ... (AGH), Forbes Hospital, Saint Vincent Hospital and West Penn ... specialties. , “There is no higher priority ...
(Date:7/23/2014)... Kathleen Doheny HealthDay Reporter ... surgery appears to have an additional side benefit -- ... to a new study. The study found that ... reported having incontinence prior to the procedure. After surgery, ... improved or disappeared, said study researcher Dr. Leslee Subak, ...
(Date:7/23/2014)... News) -- For patients infected with both HIV and ... both viruses, a small study suggests. Researchers said ... for people with the two diseases. "The ... an important role in the management of individuals with ... Kenneth Sherman, a professor of medicine at the University ...
(Date:7/23/2014)... BOSTON In a massive effort to catalog ... researchers at Dana-Farber Cancer Institute, have identified four ... other molecular abnormalities. They say the new classification ... therapies for the third-leading cancer killer worldwide. , ... of The Cancer Genome Atlas Research Network said ...
(Date:7/23/2014)... focused on the regions of the coding genome (exons) ... amino acids thus proteins. But just before each gene, ... the expression and activity of the adjacent gene. Until ... such DNA fragment in tumor development. , An ... with the group of Manel Esteller, Director of Epigenetics ...
Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... 10 Amedica Corporation, an,orthopedic implants company focused ... paper it presented on the in-vitro,testing and evaluation ... arthroplasty won the HAP Paul Award from the ... HAP Paul Award, which,was presented to Amedica at ...
... Shows Majority of Americans Would Like to See the United States ... ... a national bipartisan poll,commissioned by the US Coalition for Child Survival, ... cause of,child deaths in the world,s poorest countries. In reality, pneumonia,diarrhea, ...
... its 60th anniversary, the American Association for Cancer ... health disparities and minority cancer education. , AACEs ... Sheraton Birmingham Hotel, 2101 Richard Arrington Jr. Boulevard ... Minority and Underserved Populations. , The AACE meeting ...
... Ala., Oct. 10 Major financial implications are,at ... accurately record,the health conditions of patients that are ... the Centers for Medicare and Medicaid,Services (CMS). ... Group (DRG),assignment, including new methods for identifying patients ...
... 10 The American Medical,Student Association (AMSA), ... announced that a coalition representing the,majority of ... to pass the National Health Service Corps ... of 2007 (H.R. 2915). The NHSC ...
... YORK, Oct. 10 Buck Consultants, an ACS ... and benefits consulting firms,today announced the results of ... Buck,s study, "WORKING WELL: A Global Survey of ... 555 organizations,representing approximately 7 million employees. Such ...
Cached Medicine News:Health News:Amedica's Silicon Nitride Ceramic Bearing Technology Receives Prestigious HAP Paul Award for Use in Total Hip Arthroplasty 2Health News:Sixty Percent of Americans Cannot Name Top Killers of Kids 2Health News:Sixty Percent of Americans Cannot Name Top Killers of Kids 3Health News:US, European cancer educators gather in Alabama for meeting 2Health News:Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms 2Health News:Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms 3Health News:Coalition Urges Congress to Increase Funding for National Health Service Corps 2Health News:Coalition Urges Congress to Increase Funding for National Health Service Corps 3Health News:Buck Consultants Reports Wellness Programs Are Truly Global; Objectives Vary by Region 2Health News:Buck Consultants Reports Wellness Programs Are Truly Global; Objectives Vary by Region 3Health News:Buck Consultants Reports Wellness Programs Are Truly Global; Objectives Vary by Region 4
(Date:7/23/2014)... ROCHESTER, N.Y. , July 23, 2014 ... VSCP ), a leading provider of clinical trial ... , 48, has been named president and chief executive ... of Directors in August 2013 and has held the ... October 25, 2013. Dr. Charles E. ...
(Date:7/23/2014)... 23, 2014 Research and Markets ... in Consumer Healthcare by Application, Sensor Type & by ... 2020" report to their offering. ... an increasing momentum for consumer healthcare monitoring and sensing ... consumer healthcare will lessen the healthcare cost of the ...
(Date:7/23/2014)... MOUNTAIN VIEW, Calif. , July 23, ... in translational preclinical research, today unveiled their new logo ... the transformation of Surpass, corporate culture to one where ... customers. This press release comes on the heels of ... added to the Silicon Valley Team:  David Craig, a ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3
... Sept. 30, 2011 Haemonetics Corporation (NYSE: ... quarter of its 2012 fiscal year on October 31, ... hold a webcast to discuss and answer questions about ... 31, 2011. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4204617 ...
... Sept. 29, 2011 Boston Scientific Corporation (NYSE: ... ( NE ural C ardiac T her A ... a prospective, randomized, international clinical feasibility study designed to assess ... heart failure patients.  The study will evaluate 96 patients with ...
Cached Medicine Technology:Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 2Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 3Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 4
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With cast aluminum base • ...
... concave seats and large backrests with ... seats, backrests, armrests, and casters and ... for top performance in a variety ... clean room, static control, health care ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With cast aluminum base • ...
Medicine Products: